Apovomin 1 mg/ml Solution for Injection for Dogs

Expulsive efforts with or without vomiting are likely to be seen from 3 to 4 minutes
after the injection of the veterinary medicinal product and may last up to half an hour.
If emesis is not induced following a single injection, do not repeat the injection as it
will not be effective and may provoke clinical signs of overdose.

Special precautions for safe use in the target species:
In dogs with known severe hepatic failure, the benefit-risk balance for use of the
veterinary medicinal product should be considered by the veterinarian.
Before administering the veterinary medicinal product, consideration must be given to
the time of the ingestion of the substance (in relation to gastric emptying times) and
the suitability of inducing emesis based on the type of substance ingested (see also
section 3.3).
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This veterinary medicinal product may cause nausea and somnolence. In case of
accidental self–injection, seek medical advice immediately and show the package
leaflet or the label to the physician. DO NOT DRIVE, as sedation may occur.
Apomorphine has been shown to have teratogenic effects in laboratory animals and
is excreted in breast milk. Pregnant and breastfeeding women should avoid handling
the veterinary medicinal product.
This veterinary medicinal product may cause hypersensitivity reactions. People with
known hypersensitivity to apomorphine or to any of the excipients should avoid
contact with the veterinary medical product.
If the veterinary medicinal product comes into contact with the skin or eyes, rinse
immediately with water. Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.